Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)

Conditions:   Crohn's Disease;   IBD Interventions:   Drug: Infliximab;   Drug: Adalimumab Sponsors:   Children's Hospital Medical Center, Cincinnati;   The Leona M. and Harry B. Helmsley Charitable Trust Not yet recruiting

Source: ClinicalTrials.gov - October 18, 2019 Category: Research Source Type: clinical trials